| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30067560 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
| TVIS30067561 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
| TVIS30067562 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
| TVIS30067563 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
| TVIS44050640 | HTLV-1 | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CYP3A5 |
|---|---|
| DrugBank ID | DB14011 |
| Drug Name | Nabiximols |
| Target ID | BE0002362 |
| UniProt ID | P20815 |
| Regulation Type | inhibitor |
| PubMed IDs | 26264914 |
| Citations | Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ: Molecular Targets of Cannabidiol in Neurological Disorders. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. |
| Groups | Investigational |
| Direct Classification | |
| SMILES | [H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3833333 |
